Drug Shortage Report for ROSIGLITAZONE

Last updated on 2017-10-16 History
Report ID 20214
Drug Identification Number 02403374
Brand name APO-ROSIGLITAZONE
Common or Proper name ROSIGLITAZONE
Company Name AA PHARMA INC
Market Status MARKETED
Active Ingredient(s) ROSIGLITAZONE
Strength(s) 4MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL
ATC code A10BG
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-08-21
Estimated end date 2017-10-16
Actual end date 2017-10-13
Shortage status Resolved
Updated date 2017-10-16
Company comments
Health Canada comments
Contact Address 1165 CREDITSTONE ROAD
VAUGHAN, ONTARIO
CANADA L4K 4N7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-08-24 English Compare
v2 2017-08-24 French Compare
v3 2017-10-16 English Compare
v4 2017-10-16 French Compare